These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 9555819)

  • 1. Topical treatment of acne vulgaris: retinoids and cutaneous irritation.
    Leyden JJ
    J Am Acad Dermatol; 1998 Apr; 38(4):S1-4. PubMed ID: 9555819
    [No Abstract]   [Full Text] [Related]  

  • 2. Topical tretinoin or adapalene in acne vulgaris: an overview.
    Jain S
    J Dermatolog Treat; 2004 Jul; 15(4):200-7. PubMed ID: 15764031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative trial of two retinoids commonly used in the treatment of acne vulgaris.
    Nyirady J; Grossman RM; Nighland M; Berger RS; Jorizzo JL; Kim YH; Martin AG; Pandya AG; Schulz KK; Strauss JS
    J Dermatolog Treat; 2001 Sep; 12(3):149-57. PubMed ID: 12243706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of adapalene 0.1% solution and tretinoin 0.025% gel in the topical treatment of acne vulgaris.
    Ellis CN; Millikan LE; Smith EB; Chalker DM; Swinyer LJ; Katz IH; Berger RS; Mills OH; Baker M; Verschoore M; Loesche C
    Br J Dermatol; 1998 Oct; 139 Suppl 52():41-7. PubMed ID: 9990420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized facial tolerability studies comparing gel formulations of retinoids used to treat acne vulgaris.
    Leyden J; Grove GL
    Cutis; 2001 Jun; 67(6 Suppl):17-27. PubMed ID: 11499328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adapalene 0.1% gel for the treatment of acne vulgaris: its superiority compared to tretinoin 0.025% cream in skin tolerance and patient preference.
    Dunlap FE; Mills OH; Tuley MR; Baker MD; Plott RT
    Br J Dermatol; 1998 Oct; 139 Suppl 52():17-22. PubMed ID: 9990416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the efficacy and tolerability of adapalene 0.1% gel versus tretinoin 0.025% gel in patients with acne vulgaris: a meta-analysis of five randomized trials.
    Cunliffe WJ; Poncet M; Loesche C; Verschoore M
    Br J Dermatol; 1998 Oct; 139 Suppl 52():48-56. PubMed ID: 9990421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative study of the efficacy and tolerability of 0.1 and 0.03 p.100 adapalene gel and 0.025 p.100 tretinoin gel in the treatment of acne].
    Alirezai M; Meynadier J; Jablonska S; Czernielewski J; Verschoore M
    Ann Dermatol Venereol; 1996; 123(3):165-70. PubMed ID: 8761775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and tolerability of once-daily tazarotene 0.1% gel versus once-daily tretinoin 0.025% gel in the treatment of facial acne vulgaris: a randomized trial.
    Webster GF; Berson D; Stein LF; Fivenson DP; Tanghetti EA; Ling M
    Cutis; 2001 Jun; 67(6 Suppl):4-9. PubMed ID: 11499329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new topical retinoid--why a new topical acne therapy?
    Cunliffe WJ
    Br J Dermatol; 1998 Oct; 139 Suppl 52():1-2. PubMed ID: 9990412
    [No Abstract]   [Full Text] [Related]  

  • 11. Split-face clinical and bio-instrumental comparison of 0.1% adapalene and 0.05% tretinoin in facial acne.
    Piérard-Franchimont C; Henry F; Fraiture AL; Fumal I; Piérard GE
    Dermatology; 1999; 198(2):218-22. PubMed ID: 10325486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tazarotene 0.1 percent cream plus clindamycin 1 percent gel versus tretinoin 0.025 percent gel plus clindamycin 1 percent gel in the treatment of facial acne vulgaris.
    Tanghetti E; Dhawan S; Torok H; Kircik L
    Dermatol Online J; 2007 Jul; 13(3):1. PubMed ID: 18328195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is switching retinoids a sound strategy for the treatment of acne vulgaris?
    Gold LS; Colón LE; Johnson LA; Gottschalk RW
    J Drugs Dermatol; 2008 Jun; 7(6 Suppl):s11-7. PubMed ID: 18575221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Split-face comparison of adapalene 0.1% gel and tretinoin 0.025% gel in acne patients.
    Caron D; Sorba V; Kerrouche N; Clucas A
    J Am Acad Dermatol; 1997 Jun; 36(6 Pt 2):S110-2. PubMed ID: 9204087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spotlight on adapalene in acne vulgaris.
    Waugh J; Noble S; Scott LJ
    Am J Clin Dermatol; 2004; 5(5):369-71. PubMed ID: 15554742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomised, controlled trial of the efficacy and safety of adapalene gel 0.1% and tretinoin cream 0.05% in patients with acne vulgaris.
    Cunliffe WJ; Danby FW; Dunlap F; Gold MH; Gratton D; Greenspan A
    Eur J Dermatol; 2002; 12(4):350-4. PubMed ID: 12095880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical retinoids for acne.
    Yeh L; Bonati LM; Silverberg NB
    Semin Cutan Med Surg; 2016 Jun; 35(2):50-6. PubMed ID: 27416308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The rationale for using a topical retinoid for inflammatory acne.
    Millikan LE
    Am J Clin Dermatol; 2003; 4(2):75-80. PubMed ID: 12553848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adapalene 0.1% gel is better tolerated than tretinoin 0.025% gel in acne patients.
    Clucas A; Verschoore M; Sorba V; Poncet M; Baker M; Czernielewski J
    J Am Acad Dermatol; 1997 Jun; 36(6 Pt 2):S116-8. PubMed ID: 9204089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical adapalene gel 0.1% vs. isotretinoin gel 0.05% in the treatment of acne vulgaris: a randomized open-label clinical trial.
    Ioannides D; Rigopoulos D; Katsambas A
    Br J Dermatol; 2002 Sep; 147(3):523-7. PubMed ID: 12207595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.